Paion AG
XETRA:PA8

Watchlist Manager
Paion AG Logo
Paion AG
XETRA:PA8
Watchlist
Price: 0.25 EUR -30.56% Market Closed
Updated: May 24, 2024

Paion AG
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Paion AG
Research & Development Peer Comparison

Comparables:
BNTX
MOR
CVAC
IMTX
BIO

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Paion AG
XETRA:PA8
Research & Development
-€6.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Research & Development
-€1.8B
CAGR 3-Years
-43%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Research & Development
-€285.7m
CAGR 3-Years
-51%
CAGR 5-Years
-25%
CAGR 10-Years
-19%
CureVac NV
NASDAQ:CVAC
Research & Development
-€107.2m
CAGR 3-Years
1%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Research & Development
-€116.1m
CAGR 3-Years
-21%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Research & Development
-€81.8m
CAGR 3-Years
-25%
CAGR 5-Years
-10%
CAGR 10-Years
-2%

See Also

What is Paion AG's Research & Development?
Research & Development
-6.5m EUR

Based on the financial report for Dec 31, 2022, Paion AG's Research & Development amounts to -6.5m EUR.

What is Paion AG's Research & Development growth rate?
Research & Development CAGR 1Y
-24%

Over the last year, the Research & Development growth was -24%.